Unal, I. Et Al. 2023. Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson's disease model in zebrafish; mechanism involving ketogenesis and autophagy. BRAIN RESEARCH , vol.1820 .

Unal, I., Cansiz, D., Beler, M., SEZER, Z., Guzel, E., & ALTURFAN, E. I., (2023). Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson's disease model in zebrafish; mechanism involving ketogenesis and autophagy. BRAIN RESEARCH , vol.1820.

Unal, Ismail Et Al. "Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson's disease model in zebrafish; mechanism involving ketogenesis and autophagy," BRAIN RESEARCH , vol.1820, 2023

Unal, Ismail Et Al. "Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson's disease model in zebrafish; mechanism involving ketogenesis and autophagy." BRAIN RESEARCH , vol.1820, 2023

Unal, I. Et Al. (2023) . "Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson's disease model in zebrafish; mechanism involving ketogenesis and autophagy." BRAIN RESEARCH , vol.1820.

@article{article, author={Ismail Unal Et Al. }, title={Sodium-dependent glucose co-transporter-2 inhibitor empagliflozin exerts neuroprotective effects in rotenone-induced Parkinson's disease model in zebrafish; mechanism involving ketogenesis and autophagy}, journal={BRAIN RESEARCH}, year=2023}